Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acumen Research Laboratories is a Singapore-based biotechnology company specializing in the development and commercialization of innovative molecular diagnostic tests for infectious diseases. The company's flagship product, AcuSept, is a host-response gene expression-based assay designed for the early detection of sepsis, aiming to improve patient outcomes through rapid diagnosis. Beyond sepsis, Acumen has expanded its portfolio to include diagnostic solutions for other pathogens, including COVID-19. The company operates as a contract research organization (CRO) and a product developer, leveraging its expertise in molecular biology to support clinical research and personalized medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Acumen Research.